Core Viewpoint - The company, Qiaoyuan Co., Ltd. (301286.SZ), has signed an investment cooperation agreement with the Chengdu New Materials Industry Functional Zone Management Committee to establish a special gas production base for electronic and medical use in Chengdu, with a total planned investment of 302 million yuan [1]. Group 1: Project Investment Details - The total planned investment for the project is 302 million yuan, with the first phase requiring approximately 152 million yuan and the second phase about 150 million yuan [1]. - The first phase will cover an area of approximately 38 acres and will establish a production capacity of 20,000 tons/year for electronic-grade carbon dioxide, 20,000 tons/year for medical-grade carbon dioxide, 40,000 tons/year for industrial-grade carbon dioxide, and a hydrogen recovery and purification facility with a capacity of 1,000 Nm³/h [1]. Group 2: Strategic Importance - The first phase of the project will add 20,000 tons/year of high-purity medical-grade carbon dioxide capacity, significantly enhancing the supply of sterile gases to meet the increasing demand in biopharmaceuticals and high-end medical devices [1]. - By establishing a production line for 20,000 tons/year of electronic-grade carbon dioxide and a hydrogen recovery and purification facility, along with the planned electronic-grade ultra-pure ammonia production line in the second phase, the company aims to enter strategic emerging fields such as semiconductor manufacturing and new display technologies, extending its reach from medical gases to higher value-added electronic specialty gases [1].
侨源股份(301286.SZ)拟3.02亿元在成都投建电子级医用级特种气体生产基地